• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchTourmaline Bio
    Picture of Tourmaline Bio logo

    TRML — Tourmaline Bio News Story

    $47.900.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    • Market Cap
      $1.23bn
    • Enterprise Value
      $994.48m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • TRML Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    TRML Dividends
    All News

    NASDAQ RESUMED AT 09:44 AM

    Picture of Tourmaline Bio logoTourmaline Bio
    01/07/2022 14:44
    NASDAQ RESUMED  TALS.O  AT 09:44 AM
    

    Recent news on Tourmaline Bio

    See all news
    • Brief: Novartis Completes Acquisition Of Tourmaline Bio

      28/10/2025 13:58
    • Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer

      28/10/2025 06:26
    • Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)

      26/10/2025 15:44
    • Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio

      29/09/2025 12:50
    • U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy

      10/09/2025 18:50

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.